candesartan

Candesartan produced the greatest improvement in executive function, with TMT Part B improving by 17.1 seconds versus 4.2 seconds for HCTZ and worsening by 14.4 seconds for lisinopril, with significan

Effect: improvement; TMT-B improved by 17.1 seconds

Candesartan produced the greatest improvement in executive function, with TMT Part B improving by 17.1 seconds versus 4.2 seconds for HCTZ and worsening by 14.4 seconds for lisinopril, with significan

Effect: improvement; TMT-B improved by 17.1 seconds

Candesartan produced the greatest improvement in executive function, with TMT Part B improving by 17.1 seconds versus 4.2 seconds for HCTZ and worsening by 14.4 seconds for lisinopril, with significan

Effect: improvement; TMT-B improved by 17.1 seconds

Candesartan produced the greatest improvement in executive function, with TMT Part B improving by 17.1 seconds versus 4.2 seconds for HCTZ and worsening by 14.4 seconds for lisinopril, with significan

Effect: improvement; TMT-B improved by 17.1 seconds

Candesartan produced the greatest improvement in executive function, with TMT Part B improving by 17.1 seconds versus 4.2 seconds for HCTZ and worsening by 14.4 seconds for lisinopril, with significan

Effect: improvement; TMT-B improved by 17.1 seconds

Candesartan produced the greatest improvement in executive function, with TMT Part B improving by 17.1 seconds versus 4.2 seconds for HCTZ and worsening by 14.4 seconds for lisinopril, with significan

Effect: improvement; TMT-B improved by 17.1 seconds

Candesartan produced the greatest improvement in executive function, with TMT Part B improving by 17.1 seconds versus 4.2 seconds for HCTZ and worsening by 14.4 seconds for lisinopril, with significan

Effect: improvement; TMT-B improved by 17.1 seconds

Candesartan produced the greatest improvement in executive function, with TMT Part B improving by 17.1 seconds versus 4.2 seconds for HCTZ and worsening by 14.4 seconds for lisinopril, with significan

Effect: improvement; TMT-B improved by 17.1 seconds

Candesartan produced the greatest improvement in executive function, with TMT Part B improving by 17.1 seconds versus 4.2 seconds for HCTZ and worsening by 14.4 seconds for lisinopril, with significan

Effect: improvement; TMT-B improved by 17.1 seconds

Candesartan produced the greatest improvement in executive function, with TMT Part B improving by 17.1 seconds versus 4.2 seconds for HCTZ and worsening by 14.4 seconds for lisinopril, with significan

Effect: improvement; TMT-B improved by 17.1 seconds

Candesartan produced the greatest improvement in executive function, with TMT Part B improving by 17.1 seconds versus 4.2 seconds for HCTZ and worsening by 14.4 seconds for lisinopril, with significan

Effect: improvement; TMT-B improved by 17.1 seconds

Candesartan produced the greatest improvement in executive function, with TMT Part B improving by 17.1 seconds versus 4.2 seconds for HCTZ and worsening by 14.4 seconds for lisinopril, with significan

Effect: improvement; TMT-B improved by 17.1 seconds

Candesartan produced the greatest improvement in executive function, with TMT Part B improving by 17.1 seconds versus 4.2 seconds for HCTZ and worsening by 14.4 seconds for lisinopril, with significan

Effect: improvement; TMT-B improved by 17.1 seconds

Candesartan produced the greatest improvement in executive function, with TMT Part B improving by 17.1 seconds versus 4.2 seconds for HCTZ and worsening by 14.4 seconds for lisinopril, with significan

Effect: improvement; TMT-B improved by 17.1 seconds

Candesartan produced the greatest improvement in executive function, with TMT Part B improving by 17.1 seconds versus 4.2 seconds for HCTZ and worsening by 14.4 seconds for lisinopril, with significan

Effect: improvement; TMT-B improved by 17.1 seconds

Candesartan produced the greatest improvement in executive function, with TMT Part B improving by 17.1 seconds versus 4.2 seconds for HCTZ and worsening by 14.4 seconds for lisinopril, with significan

Effect: improvement; TMT-B improved by 17.1 seconds

Candesartan produced the greatest improvement in executive function, with TMT Part B improving by 17.1 seconds versus 4.2 seconds for HCTZ and worsening by 14.4 seconds for lisinopril, with significan

Effect: improvement; TMT-B improved by 17.1 seconds

Candesartan produced the greatest improvement in executive function, with TMT Part B improving by 17.1 seconds versus 4.2 seconds for HCTZ and worsening by 14.4 seconds for lisinopril, with significan

Effect: improvement; TMT-B improved by 17.1 seconds

Candesartan produced the greatest improvement in executive function, with TMT Part B improving by 17.1 seconds versus 4.2 seconds for HCTZ and worsening by 14.4 seconds for lisinopril, with significan

Effect: improvement; TMT-B improved by 17.1 seconds

Candesartan produced the greatest improvement in executive function, with TMT Part B improving by 17.1 seconds versus 4.2 seconds for HCTZ and worsening by 14.4 seconds for lisinopril, with significan

Effect: improvement; TMT-B improved by 17.1 seconds

Candesartan produced the greatest improvement in executive function, with TMT Part B improving by 17.1 seconds versus 4.2 seconds for HCTZ and worsening by 14.4 seconds for lisinopril, with significan

Effect: improvement; TMT-B improved by 17.1 seconds

Candesartan produced the greatest improvement in executive function, with TMT Part B improving by 17.1 seconds versus 4.2 seconds for HCTZ and worsening by 14.4 seconds for lisinopril, with significan

Effect: improvement; TMT-B improved by 17.1 seconds

Candesartan produced the greatest improvement in executive function, with TMT Part B improving by 17.1 seconds versus 4.2 seconds for HCTZ and worsening by 14.4 seconds for lisinopril, with significan

Effect: improvement; TMT-B improved by 17.1 seconds

Candesartan produced the greatest improvement in executive function, with TMT Part B improving by 17.1 seconds versus 4.2 seconds for HCTZ and worsening by 14.4 seconds for lisinopril, with significan

Effect: improvement; TMT-B improved by 17.1 seconds

Candesartan produced the greatest improvement in executive function, with TMT Part B improving by 17.1 seconds versus 4.2 seconds for HCTZ and worsening by 14.4 seconds for lisinopril, with significan

Effect: improvement; TMT-B improved by 17.1 seconds

Candesartan produced the greatest improvement in executive function, with TMT Part B improving by 17.1 seconds versus 4.2 seconds for HCTZ and worsening by 14.4 seconds for lisinopril, with significan

Effect: improvement; TMT-B improved by 17.1 seconds

Candesartan produced the greatest improvement in executive function, with TMT Part B improving by 17.1 seconds versus 4.2 seconds for HCTZ and worsening by 14.4 seconds for lisinopril, with significan

Effect: improvement; TMT-B improved by 17.1 seconds

All three antihypertensive regimens achieved equivalent systolic blood pressure reductions and blood pressure control rates, establishing that cognitive and hemodynamic differences between groups are

Effect: null; Lisinopril: -27±5 mmHg; Candesartan: -26±5 mmHg; HCTZ: -25±6 mmHg; p=0.93

All three antihypertensive regimens achieved equivalent systolic blood pressure reductions and blood pressure control rates, establishing that cognitive and hemodynamic differences between groups are

Effect: null; Lisinopril: -27±5 mmHg; Candesartan: -26±5 mmHg; HCTZ: -25±6 mmHg; p=0.93

All three antihypertensive regimens achieved equivalent systolic blood pressure reductions and blood pressure control rates, establishing that cognitive and hemodynamic differences between groups are

Effect: null; Lisinopril: -27±5 mmHg; Candesartan: -26±5 mmHg; HCTZ: -25±6 mmHg; p=0.93

All three antihypertensive regimens achieved equivalent systolic blood pressure reductions and blood pressure control rates, establishing that cognitive and hemodynamic differences between groups are

Effect: null; Lisinopril: -27±5 mmHg; Candesartan: -26±5 mmHg; HCTZ: -25±6 mmHg; p=0.93

All three antihypertensive regimens achieved equivalent systolic blood pressure reductions and blood pressure control rates, establishing that cognitive and hemodynamic differences between groups are

Effect: null; Lisinopril: -27±5 mmHg; Candesartan: -26±5 mmHg; HCTZ: -25±6 mmHg; p=0.93

All three antihypertensive regimens achieved equivalent systolic blood pressure reductions and blood pressure control rates, establishing that cognitive and hemodynamic differences between groups are

Effect: null; Lisinopril: -27±5 mmHg; Candesartan: -26±5 mmHg; HCTZ: -25±6 mmHg; p=0.93

All three antihypertensive regimens achieved equivalent systolic blood pressure reductions and blood pressure control rates, establishing that cognitive and hemodynamic differences between groups are

Effect: null; Lisinopril: -27±5 mmHg; Candesartan: -26±5 mmHg; HCTZ: -25±6 mmHg; p=0.93

All three antihypertensive regimens achieved equivalent systolic blood pressure reductions and blood pressure control rates, establishing that cognitive and hemodynamic differences between groups are

Effect: null; Lisinopril: -27±5 mmHg; Candesartan: -26±5 mmHg; HCTZ: -25±6 mmHg; p=0.93

All three antihypertensive regimens achieved equivalent systolic blood pressure reductions and blood pressure control rates, establishing that cognitive and hemodynamic differences between groups are

Effect: null; Lisinopril: -27±5 mmHg; Candesartan: -26±5 mmHg; HCTZ: -25±6 mmHg; p=0.93

All three antihypertensive regimens achieved equivalent systolic blood pressure reductions and blood pressure control rates, establishing that cognitive and hemodynamic differences between groups are

Effect: null; Lisinopril: -27±5 mmHg; Candesartan: -26±5 mmHg; HCTZ: -25±6 mmHg; p=0.93

All three antihypertensive regimens achieved equivalent systolic blood pressure reductions and blood pressure control rates, establishing that cognitive and hemodynamic differences between groups are

Effect: null; Lisinopril: -27±5 mmHg; Candesartan: -26±5 mmHg; HCTZ: -25±6 mmHg; p=0.93

All three antihypertensive regimens achieved equivalent systolic blood pressure reductions and blood pressure control rates, establishing that cognitive and hemodynamic differences between groups are

Effect: null; Lisinopril: -27±5 mmHg; Candesartan: -26±5 mmHg; HCTZ: -25±6 mmHg; p=0.93

All three antihypertensive regimens achieved equivalent systolic blood pressure reductions and blood pressure control rates, establishing that cognitive and hemodynamic differences between groups are

Effect: null; Lisinopril: -27±5 mmHg; Candesartan: -26±5 mmHg; HCTZ: -25±6 mmHg; p=0.93

All three antihypertensive regimens achieved equivalent systolic blood pressure reductions and blood pressure control rates, establishing that cognitive and hemodynamic differences between groups are

Effect: null; Lisinopril: -27±5 mmHg; Candesartan: -26±5 mmHg; HCTZ: -25±6 mmHg; p=0.93

All three antihypertensive regimens achieved equivalent systolic blood pressure reductions and blood pressure control rates, establishing that cognitive and hemodynamic differences between groups are

Effect: null; Lisinopril: -27±5 mmHg; Candesartan: -26±5 mmHg; HCTZ: -25±6 mmHg; p=0.93

All three antihypertensive regimens achieved equivalent systolic blood pressure reductions and blood pressure control rates, establishing that cognitive and hemodynamic differences between groups are

Effect: null; Lisinopril: -27±5 mmHg; Candesartan: -26±5 mmHg; HCTZ: -25±6 mmHg; p=0.93

All three antihypertensive regimens achieved equivalent systolic blood pressure reductions and blood pressure control rates, establishing that cognitive and hemodynamic differences between groups are

Effect: null; Lisinopril: -27±5 mmHg; Candesartan: -26±5 mmHg; HCTZ: -25±6 mmHg; p=0.93

All three antihypertensive regimens achieved equivalent systolic blood pressure reductions and blood pressure control rates, establishing that cognitive and hemodynamic differences between groups are

Effect: null; Lisinopril: -27±5 mmHg; Candesartan: -26±5 mmHg; HCTZ: -25±6 mmHg; p=0.93

All three antihypertensive regimens achieved equivalent systolic blood pressure reductions and blood pressure control rates, establishing that cognitive and hemodynamic differences between groups are

Effect: null; Lisinopril: -27±5 mmHg; Candesartan: -26±5 mmHg; HCTZ: -25±6 mmHg; p=0.93

All three antihypertensive regimens achieved equivalent systolic blood pressure reductions and blood pressure control rates, establishing that cognitive and hemodynamic differences between groups are

Effect: null; Lisinopril: -27±5 mmHg; Candesartan: -26±5 mmHg; HCTZ: -25±6 mmHg; p=0.93

All three antihypertensive regimens achieved equivalent systolic blood pressure reductions and blood pressure control rates, establishing that cognitive and hemodynamic differences between groups are

Effect: null; Lisinopril: -27±5 mmHg; Candesartan: -26±5 mmHg; HCTZ: -25±6 mmHg; p=0.93

All three antihypertensive regimens achieved equivalent systolic blood pressure reductions and blood pressure control rates, establishing that cognitive and hemodynamic differences between groups are

Effect: null; Lisinopril: -27±5 mmHg; Candesartan: -26±5 mmHg; HCTZ: -25±6 mmHg; p=0.93

All three antihypertensive regimens achieved equivalent systolic blood pressure reductions and blood pressure control rates, establishing that cognitive and hemodynamic differences between groups are

Effect: null; Lisinopril: -27±5 mmHg; Candesartan: -26±5 mmHg; HCTZ: -25±6 mmHg; p=0.93